Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuma is a specialized healthcare company that provides commercial and market access solutions for innovative biopharmaceutical products in the Middle East and North Africa (MENA) region. Headquartered in Dubai, the company serves as a strategic partner for global biotechnology firms looking to navigate the complex regulatory and commercial landscapes of the GCC. Yuma's core expertise lies in the management of specialty therapeutics, particularly in the fields of rare diseases, oncology, and hematology. The company offers a comprehensive suite of services including regulatory affairs, medical marketing, and specialized cold-chain distribution. By focusing on high-unmet-need therapeutic areas, Yuma ensures that patients in the region have access to life-saving orphan drugs and advanced medical treatments. The organization is recognized for its deep local market knowledge and commitment to ethical healthcare practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuma Emirates.